{
    "title": "J&J starts two-dose trial of its COVID-19 candidate vaccine in the UK",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8952107/J-J-starts-two-dose-trial-COVID-19-candidate-vaccine-UK.html",
    "date": "2020-11-16",
    "keywords": [
        "trial",
        "vaccine",
        "shot",
        "kate",
        "kelland",
        "latestage",
        "britain",
        "study",
        "uk",
        "dose",
        "faust",
        "efficacy",
        "johnson",
        "monday",
        "geography",
        "arm",
        "total",
        "placebo",
        "ad26cov2",
        "saul",
        "professor",
        "immunology",
        "university",
        "hospital",
        "southampton",
        "jampj",
        "agreement",
        "phase",
        "government",
        "august",
        "parallel",
        "september",
        "company",
        "distribution",
        "pfizer",
        "biontech",
        "week",
        "covid19",
        "disease",
        "use",
        "pfizerbiontech",
        "technology",
        "messenger",
        "rna",
        "jampjs",
        "virus",
        "material",
        "coronavirus",
        "body",
        "response",
        "platform",
        "advac",
        "ebola",
        "year",
        "supply",
        "population",
        "briefing",
        "location",
        "march",
        "jan",
        "harvey"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}